HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure.

Abstract
Treatment with L-threo-3,4-dihydroxyphenylserine (L-threo-dops), a synthetic precursor of norepinephrine, significantly increased upright blood pressure in patients with multiple system atrophy but had no effect on the upright blood pressure of patients with pure autonomic failure. These results suggest that the site of action of L-threo-dops is central and that its pressor effect requires intact peripheral sympathetic neurons.
AuthorsH Kaufmann, E Oribe, M D Yahr
JournalJournal of neural transmission. Parkinson's disease and dementia section (J Neural Transm Park Dis Dement Sect) Vol. 3 Issue 2 Pg. 143-8 ( 1991) ISSN: 0936-3076 [Print] Austria
PMID1910486 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Droxidopa
  • Norepinephrine
Topics
  • Adult
  • Aged
  • Atrophy
  • Autonomic Nervous System Diseases (pathology, physiopathology)
  • Blood Pressure (drug effects)
  • Droxidopa (pharmacology)
  • Humans
  • Hypotension, Orthostatic
  • Kinetics
  • Middle Aged
  • Norepinephrine (blood)
  • Supine Position

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: